Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 78.37

-1.2%

Dec 17 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (2466)	1/21/2009 11:27:31 PM
From: Jibacoa	Read Replies (1) of 3722

TKMRF Announced earlier this month that it expects to receive a minimum of $11.2M over the next 3Yrs.from ALNY as part of its manufacturing relationship with ALNY through PII for RNAi therapeutics that utilize Tekmira's SNALP technology, including ALNY's product candidate ALN-VSP. The manufacturing and development funding is in addition to ongoing research activities between the two companies and in addition to any milestone payments that TKMRF may receive from ALNY. The stock has more than doubled from its Dec L, but it could still have some potential left. :>) finance.yahoo.com The May27 H was $1.44 and the Oct9 2007 $1.79 Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next